Abstract
BackgroundOur previous study showed 11.2% of Chinese patients with rheumatoid Arthritis (RA) suffered chronic Hepatitis B virus (HBV) infection (HBsAg+) and 32.3% suffered past HBV infection (anti-HBc+/HBsAg-). Tocilizumab (TCZ) was...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
